Original paper<br>Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue

Original paper<br>Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue

Introduction: The aim of the study was the assesment of effective ablative dose of absorbed 131I radiation, based on dosimetric measurements. Material and methods: The study group comprised one hundred (100) patients in whom papillary thyroid carcinoma (PTC, 54 cases) and follicular thyroid carcinom...

Full description

Bibliographic Details
Main Authors:	Zbigniew Adamczewski, Jacek Makarewicz, Andrzej Lewiński
Format:	Article
Language:	English
Published:	Termedia Publishing House 2007-06-01
Series:	Archives of Medical Science
Subjects:	differentiated thyroid carcinoma radioiodine-131 dosimetry ablation
Online Access:	http://www.termedia.pl/magazine.php?magazine_id=19&article_id=8498&magazine_subpage=FULL_TEXT

Similar Items

Correlation between remnant thyroid gland I-131 uptake and serum thyroglobulin levels: can we rely on I-131 whole body scans?
by: Sang Hyun Hwang, et al.
Published: (2024-01-01)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
by: Alexandru Mester, et al.
Published: (2021-04-01)

Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism
by: Joachim N. Nilsson, et al.
Published: (2022-04-01)

Case report<Br>Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia (CLL)
by: Jacek Makarewicz, et al.
Published: (2007-06-01)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
by: Seyed Mohammad Javad Mortazavi, et al.
Published: (2023-01-01)

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer
by: Xian Qiu, et al.
Published: (2022-11-01)

Aplicaciones clínicas del radioyodo 131 (I131) en las enfermedades del tiroides Clinical applications of radioiodine 131 (I131) in the thyroid diseases
by: Levi González Rivero, et al.
Published: (2012-12-01)

Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases
by: Martin Andersson, et al.
Published: (2021-03-01)

Pulmonary sequestration: a rare cause of false-positive uptake in Iodine-131 whole-body scan
by: Mohd Fazrin Mohd Rohani, et al.
Published: (2022-02-01)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
by: Aleksandra Kukulska, et al.
Published: (2020-08-01)

Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
by: Chen Wang, et al.
Published: (2018-12-01)

Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
by: Doina Piciu, et al.
Published: (2023-04-01)

Evaluation of biokinetics and dosimetry in [131I]-NaI therapies: whole-body images quantification versus lower limb region
by: Bianca Lemos Lima, et al.
Published: (2020-06-01)

Radioiodine therapy activity 550 MBq of I131 in thyrotoxicosis patients
by: Marina S. Sheremeta, et al.
Published: (2016-10-01)

TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
by: Nianting Ju, et al.
Published: (2023-06-01)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
by: Chae Moon Hong, et al.
Published: (2017-10-01)

Measurement of Radiation Exposure to Caregivers of Patients with Thyroid Diseases Treated with Iodine-131: A Review
by: Ali Abdulhasan Kadhim, et al.
Published: (2020-09-01)

A Comparison between High Ablative Versus Usual Dosages of Iodine-131 in Inducing Hypothyroidism After One Year of Therapy in Hyperthyroid Patients
by: Thamer S Flayyeh
Published: (2020-01-01)

Evaluation of Discordance in Differentiated Thyroid Cancer Patients with Negative Radioiodine Scans and Positive Thyroglobulin Values at the Ablation Outcome Control
by: Zeynep Gözde Özkan, et al.
Published: (2012-03-01)

Iodine 131 ablation of an obstructive lingual thyroid
by: Lester Johnson, et al.
Published: (2009-01-01)

Quantitative monitoring of 131I in iodine cartridge using probability density calibration method of disk source
by: XU Feng, et al.
Published: (2022-08-01)

Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches
by: Stefania Mazzaglia, et al.
Published: (2019-08-01)

Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy
by: Fadi Khreish, et al.
Published: (2024-04-01)

Iodine-131 S values for use in organ dose estimation of Korean patients in radioiodine therapy
by: Yeon Soo Yeom, et al.
Published: (2022-02-01)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
by: Elizabeth J. de Koster, et al.
Published: (2021-03-01)

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative <sup>131</sup>I Administration: A Real Life Study
by: Alfredo Campennì, et al.
Published: (2023-04-01)

In clinically hyperthyroid cats, is I-131 treatment superior to thyroidectomy in normalising serum T4 level?
by: Alexander Davies
Published: (2022-12-01)

Radiation Exposure Levels in Family Members of Omani Patients with Thyrotoxicosis Treated with Radioiodine (131I) as Outpatients
by: Ibtisaam Al-Maskery, et al.
Published: (2009-08-01)

Implementation of internal monitoring programs for workers occupationally exposed by 131I in nuclear medicine services in Brazil
by: Salomão Marques de Oliveira, et al.
Published: (2018-07-01)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated 131I dose
by: Ka Kit Wong, et al.
Published: (2018-11-01)

Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
by: Ian D Hay, et al.
Published: (2023-01-01)

Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone
by: G.J. Paz-Filho, et al.
Published: (2007-12-01)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
by: Jonathan Gear, et al.
Published: (2020-03-01)

On the use of solid 133Ba sources as surrogate for liquid 131I in SPECT/CT calibration: a European multi-centre evaluation
by: Johannes Tran-Gia, et al.
Published: (2023-11-01)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
by: Luis Felipe Zavala, et al.
Published: (2019-04-01)

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
by: Shirlei Kugler Aiçar Súss, et al.
Published: (2018-04-01)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen<sup>®</sup>, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease
by: Ana Claudia R. Durante, et al.
Published: (2019-02-01)

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
by: Erin Fanning, et al.
Published: (2018-12-01)

Immunomodulatory Effects of Omega-3 Fatty Acids in Patients with Differentiated Thyroid Cancer Before or After Radioiodine Ablation
by: Zeinab Amirkhani, et al.
Published: (2022-03-01)

Multiple Bone Metastases in a Patient with Differentiated Thyroid Cancer (DTC) : Complete resolution following thyroidectomy and four ablation doses of I-131
by: Omayma T Elshafie, et al.
Published: (2010-04-01)